UNTREATED AML

Clinical trials for UNTREATED AML explained in plain language.

Never miss a new study

Get alerted when new UNTREATED AML trials appear

Sign up with your email to follow new studies for UNTREATED AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New combo shows promise for Hard-to-Treat leukemia

Disease control Ongoing

This study tests whether adding the targeted drug ivosidenib to standard azacitidine helps adults with a specific genetic form of acute myeloid leukemia (IDH1-mutated AML) who cannot receive intensive chemotherapy. About 146 participants received either the combo or a placebo plu…

Matched conditions: UNTREATED AML

Phase: PHASE3 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control

Last updated May 15, 2026 11:57 UTC

UNTREATED AML

Get alerted when new UNTREATED AML trials appear

New combo shows promise for Hard-to-Treat leukemia